The over-expression of FOXO3a in CML cells combined with TKIs to reduce proliferation, with similar results seen for inhibitors of PI3K/AKT/mTOR signaling. The gene discussed is MTOR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.